bioRxiv · 10.1101/2025.03.20.644287
Animal-free recombinant nanobody rescues HCN4 channel deficit in sinus node dysfunction
Abstract
Hyperpolarization-activated cyclic nucleotide-gated channels (HCN1-4) control cardiac and neuronal firing and their dysfunction leads to cardiac arrythmias (HCN4), epilepsy (HCN1) and chronic pain (HCN2). Prompted by the urgent need for HCN subtype-specific treatments, we screened a recombinant nanobody library in search of HCN4-specific binders. Here we show that nanobody 5 (NB5) binds to the extracellular side of HCN4 with high specificity and nanomolar affinity and activates the channel by a non-canonical electromechanical coupling path. In ex vivo and in vitro experiments, NB5 acts as an agonist of the pacemaker current If, increasing the firing rate of rabbit cardiac pacemaker myocytes and of human derived cardiomyocytes. Notably, NB5 rescued the effects of a LOF HCN4 mutation causing sinus node dysfunction in a patient. Our work illustrates that animal-free recombinant nanobodies have strong potential as next generation modulators for clinical application in symptomatic bradycardia.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Sharifzadeh, A. S., Castelli, R., Porro, A., Mesirca, P., Perrier, R., Gomez, A. M., Benoit, H., Meli, A. C., Palloni, L. M. G., DiFrancesco, D., Mangoni, M. E., Thiel, G., Saponaro, A., Moroni, A.. 2025-03-23. Animal-free recombinant nanobody rescues HCN4 channel deficit in sinus node dysfunction. https://doi.org/10.1101/2025.03.20.644287
Cite the original work for its findings. Save a collection to share your selection of sources.